Artiva Biotherapeutics Inc. (ARTV)
Market Closed
30 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
10. 43
+0.41
+4.0918%
$
250.38M Market Cap
- P/E Ratio
- Div Yield
226,417 Volume
- Eps
$ 10.02
Previous Close Analysts:
Want to track ARTV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Artiva Biotherapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Jim Harding Propel Bio Management LLC | 146,369 | $949,817.99 | $1.42M | $472,713.05 | 49.77% |
